Status:
COMPLETED
Validation of the GMFM-88 Scale and of the FAAP-O Scale in Pediatric Patients Affected by Cancer
Lead Sponsor:
Associazione Italiana Ematologia Oncologia Pediatrica
Conditions:
Oncology
Eligibility:
All Genders
6-17 years
Brief Summary
The primary objective of this study is to validate the Gross Motor Function Measure Scale-88 (GMFM-88) on the Italian pediatric cancer population. The secondary objective is to implement the use of th...
Detailed Description
In recent decades, improvements in the treatment of pediatric cancer patients have resulted in increased survival rates. Consequentially, clinicians now pay more attention to the quality of life of th...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- age between 6 months - 17 years and 11 months
- diagnosis of oncological disease
- being during antineoplastic treatment or up to 1 year off-therapy
- Written informed consent from patient or parents/legal representative, and age-appropriate assent.
- Exclusion criteria:
- • Patients that are not able and willing to comply with study visits and procedures.
Exclusion
Key Trial Info
Start Date :
November 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 22 2023
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT04862130
Start Date
November 14 2019
End Date
May 22 2023
Last Update
January 31 2024
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS E. Medea La Nostra Famiglia
Bosisio Parini, Lecco, Italy, 23842
2
IRCCS E. Medea La Nostra Famiglia
Conegliano, Treviso, Italy, 31015
3
Ospedale Papa Giovanni XXIII, UOS Onco-ematologia Pediatrica
Bergamo, Italy, 24127
4
Ospedale Azienda Sanitaria dell'Alto Adige - Comprensorio di Bolzano Servizio di Riabilitazione Fisica
Bolzano, Italy, 39100